Investigational New Drug (IND) application is a big milestone in the lengthy new drug development process, and innovators are looking for a fast and cost-effective approach to bringing their new drugs from late discovery to IND submission from CDMO partners. We offer an integrated pre-formulation service for our late discovery phase and early development stage customers – “IEPP: IND Enabling Pre-formulation Package” to provide a fast and optimal preformulation and drug delivery technology assessment including animal PK studies to give their molecules the best chance of success at later stages, all in 8-12 weeks.
Menu
CONNECT WITH US
